To our knowledge, in the currently available literature, there is no information on the plasma levels of above-mentioned oxidatively modified forms of albumin, that is AOPP and IMA, in terms of their connection with risk factors of metabolic syndrome [5, 22]. The gene discussed is ALB; the disease is metabolic syndrome.